Visceral leishmaniasis in a rheumatoid arthritis patient treated with methotrexate

International Journal of Infectious Diseases

Volumn 13, Issue 4, 2009, Pages

  Venizelos, Ioannis ^a   Tatsiou, Zoi ^a   Papathomas, Thomas G ^a   Orazi, Attilio ^b  

^a Aristotle University of Thessaloniki   (Greece)

^b Laboratory Medicine   (United States)

Author keywords

Immunopathology; Methotrexate; Rheumatoid arthritis; Visceral leishmaniasis

Indexed keywords

AMPHOTERICIN B LIPID COMPLEX; METHOTREXATE;

ABDOMINAL DISCOMFORT; AGED; ARTICLE; CASE REPORT; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; FEMALE; FEVER; HUMAN; IMMUNE DYSREGULATION; IMMUNOCOMPETENT CELL; PANCYTOPENIA; RHEUMATOID ARTHRITIS; SPLENECTOMY; SPLENOMEGALY; VISCERAL LEISHMANIASIS;

AGED; AMPHOTERICIN B; ANIMALS; ANTIPROTOZOAL AGENTS; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; FEMALE; HUMANS; LEISHMANIA; LEISHMANIASIS, VISCERAL; METHOTREXATE; SPLENECTOMY; TREATMENT OUTCOME;

EID: 67349087950     PISSN: 12019712     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijid.2008.09.012     Document Type: Article

References (22)

1. Lipsky P.E. Rheumatoid arthritis. In: Kasper D.L., Braunwald E., Fauci A.S., Hauser S.L., Longo D.L., and Jameson J.L. (Eds). Harrison's principles of internal medicine (2005), McGraw-Hill, New York 1968-1977
2. Pearson R.D., and Sousa A.Q. Clinical spectrum of Leishmaniasis. Clin Infect Dis 22 (1996) 1-13
3. Pfaller M.A. Parasitology. In: McClatchey K.D. (Ed). Clinical Laboratory Medicine (2002), Lippincott Williams & Wilkins, Philadelphia 1300-1302
4. Choi C.M., and Lerner E.A. Leishmaniasis: recognition and management with a focus on the immunocompromised patient. Am J Clin Dermatol 3 (2002) 91-105
5. Chappuis F., Sundar S., Hailu A., Ghalib H., Rijal S., Peeling R.W., et al. Visceral leishmaniasis: what are the needs for diagnosis, treatment and control?. Nat Rev Microbiol 5 (2007) 873-882
6. Pittalis S., Nicastri E., Spinazzola F., Ghirga P., De Marco M., Paglia M.G., et al. Leishmania infantum leishmaniasis in corticosteroid-treated patients. BMC Infect Dis 6 (2006) 177
7. Harms G., Schönian G., and Feldmeier H. Leishmaniasis in Germany. Emerg Infect Dis 9 (2003) 872-875
8. Weisser M., Khanlari B., Terracciano L., Arber C., Gratwohl A., Bassetti S., et al. Visceral leishmaniasis: a threat to immunocompromised patients in non-endemic areas?. Clin Microbiol Infect 13 (2007) 751-753
9. Kopterides P., Mourtzoukou E.G., Skopelitis E., Tsavaris N., and Falagas M.E. Aspects of the association between leishmaniasis and malignant disorders. Trans R Soc Trop Med Hyg 101 (2007) 1181-1189
10. Basset D., Faraut F., Marty P., Dereure J., Rosenthal E., Mary C., et al. Visceral leishmaniasis in organ transplant recipients: 11 new cases and a review of the literature. Microbes Infect 7 (2005) 1370-1375
11. Nylén S., Maurya R., Eidsmo L., Manandhar K.D., Sundar S., and Sacks D. Splenic accumulation of IL-10 mRNA in T cells distinct from CD4+CD25+ (Foxp3) regulatory T cells in human visceral leishmaniasis. J Exp Med 204 (2007) 805-817
12. Nylén S., and Sacks D. Interleukin-10 and the pathogenesis of human visceral leishmaniasis. Trends Immunol 28 (2007) 378-384
13. Stanley A.C., and Engwerda C.R. Balancing immunity and pathology in visceral leishmaniasis. Immunol Cell Biol 85 (2007) 138-147
14. Burke J.S. The spleen. In: Mills S.E., Carter D., Greenson J.K., Oberman H.A., Reuter V., and Stoler M.H. (Eds). Sternberg's diagnostic surgical pathology (2004), Lippincott Williams and Wilkins, Philadelphia 850-852
15. Fishman D., and Isenberg D.A. Splenic involvement in rheumatic diseases. Semin Arthritis Rheum 27 (1997) 141-155
16. Nishiya K., Hisakawa N., Hosokawa T., Hashimoto K., and Doi T. Enlarged spleen detected by abdominal ultrasonography in patients with RA. Ann Rheum Dis 59 (2000) 751-752
17. Winthrop K.L. Serious infections with antirheumatic therapy: are biologicals worse?. Ann Rheum Dis 65 (2006) 54-57
18. Pizzorni C., Secchi M.E., and Cutolo M. Leishmaniasis in rheumatoid arthritis. Reumatismo 59 (2007) 235-239
19. Bassetti M., Pizzorni C., Gradoni L., Del Bono V., Cutolo M., and Viscoli C. Visceral leishmaniasis infection in a rheumatoid arthritis patient treated with adalimumab. Rheumatology (Oxford) 45 (2006) 1446-1448
20. Fabre S., Gibert C., Lechiche C., Dereure J., Jorgensen C., and Sany J. Visceral leishmaniasis infection in a rheumatoid arthritis patient treated with infliximab. Clin Exp Rheumatol 6 (2005) 891-892
21. Bagalas V., Kioumis I., Argyropoulou P., and Patakas D. Visceral leishmaniasis infection in a patient with rheumatoid arthritis treated with etanercept. Clin Rheumatol 26 (2007) 1344-1345
22. Baixauli Rubio A., Rodríguez Górriz E., Campos Fernández C., Calvo Catalá J., and García Vicente S. Rare opportunistic disease in a patient treated with immunosuppressive therapy for rheumatoid arthritis. An Med Interna 20 (2003) 276-277